United States · FDA National Drug Code directory
PYLARIFY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71258-022_db2acb00-3e3b-4ecc-b532-08e456075404
- Product NDC
- 71258-022
- Form
- INJECTION
- Composition / generic term
- PIFLUFOLASTAT F-18
- Labeler
- Progenics Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210526
- Source listing expiry
- 20271231
Source-listed ingredients
- PIFLUFOLASTAT F-18 — 80 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 mL in 1 VIAL, MULTI-DOSE (71258-022-01) · 71258-022-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →